Survodutide vs Tesamorelin
Extensively Studied vs FDA Approved
monitor Mechanism-based · 55% Both Survodutide and Tesamorelin affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine).
Molecular Data
Survodutide Tesamorelin
Weight ~4,500 Da 5,135.9 Da
Half-life Approximately 6 days (109-115 hours) 26-38 minutes
Chain 29 amino acids 44 amino acids
Type Peptide with fatty acid acylation GHRH analog
Key Benefits
Survodutide
01 Superior weight loss vs monotherapy (14.9% at 46 weeks)
02 Once-weekly convenient dosing
03 Proven efficacy in obesity, MASH, and Type 2 diabetes
04 62% MASH improvement in clinical trials
Tesamorelin
01 FDA-approved formulation
02 Selective visceral fat targeting (15-20% reduction)
03 Proven clinical efficacy
04 Standardized dosing
05 37% liver fat reduction in NAFLD
06 Preserved subcutaneous fat
Dosing Protocols
Survodutide
0.6mg starting, titrate up to 3.6-6.0mg weekly / Once weekly (same day each week)
Obesity - Conservative Start 0.6mg titrated over 24 weeks Once weekly with 4-week intervals
Obesity - Standard Protocol 3.6-6.0mg Once weekly
MASH Treatment 2.4-4.8mg Once weekly
Type 2 Diabetes 0.3-2.7mg Once weekly
Tesamorelin
1.4-2mg daily (FDA-approved: 2mg for HIV lipodystrophy) / Once daily (evening preferred for GH rhythm)
HIV Lipodystrophy (FDA-approved) 1.4mg Once daily
Visceral Fat Reduction 2mg Once daily
Anti-aging/Body Composition 1-2mg 5-7x weekly
NAFLD Treatment 2mg Once daily (12 months)
Cognitive Enhancement 1mg Once daily (20 weeks)
Side Effects
Survodutide
Nausea (40-66%)
Diarrhea (25-49%)
Vomiting (15-41%)
Slight heart rate increase (mean 2-5 bpm)
Tesamorelin
Injection site reactions (17%)
Joint pain (13%)
Water retention
Contraindications
Not recommended in pregnancy or breastfeeding
Use contraception during treatment
Active malignancy
Pituitary disorders
Pregnancy
Research Evidence
Survodutide Tesamorelin
Status Extensively Studied FDA Approved
References 3 studies 5 studies
Latest — June 2025
FDA Approved No Yes
More comparisons: Metformin
This comparison is for educational and research purposes only. Consult a healthcare professional before use.